154 related articles for article (PubMed ID: 33251165)
1. Neonatal Adverse Outcomes of Induction and Expectant Management in Fetal Growth Restriction: A Systematic Review and Meta-Analysis.
Li T; Wang Y; Miao Z; Lin Y; Yu X; Xie K; Ding H
Front Pediatr; 2020; 8():558000. PubMed ID: 33251165
[No Abstract] [Full Text] [Related]
2. Predictive accuracy of cerebroplacental ratio for adverse perinatal and neurodevelopmental outcomes in suspected fetal growth restriction: systematic review and meta-analysis.
Conde-Agudelo A; Villar J; Kennedy SH; Papageorghiou AT
Ultrasound Obstet Gynecol; 2018 Oct; 52(4):430-441. PubMed ID: 29920817
[TBL] [Abstract][Full Text] [Related]
3. More Maternal Vascular Malperfusion and Chorioamnionitis in Placentas After Expectant Management vs. Immediate Delivery in Fetal Growth Restriction at (Near) Term: A Further Analysis of the DIGITAT Trial.
Feenstra ME; Schoots MH; Plösch T; Prins JR; Scherjon SA; Timmer A; van Goor H; Gordijn SJ
Front Endocrinol (Lausanne); 2019; 10():238. PubMed ID: 31105647
[No Abstract] [Full Text] [Related]
4. Caesarean section rates and adverse neonatal outcomes after induction of labour versus expectant management in women with an unripe cervix: a secondary analysis of the HYPITAT and DIGITAT trials.
Bernardes TP; Broekhuijsen K; Koopmans CM; Boers KE; van Wyk L; Tajik P; van Pampus MG; Scherjon SA; Mol BW; Franssen MT; van den Berg PP; Groen H
BJOG; 2016 Aug; 123(9):1501-8. PubMed ID: 27173131
[TBL] [Abstract][Full Text] [Related]
5. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
[TBL] [Abstract][Full Text] [Related]
6. Expectant management of pregnancies complicated by fetal growth restriction without any evidence of placental dysfunction at term: Comparison with routine labor induction.
Hidaka N; Sato Y; Kido S; Fujita Y; Kato K
J Obstet Gynaecol Res; 2018 Jan; 44(1):93-101. PubMed ID: 28892225
[TBL] [Abstract][Full Text] [Related]
7. The Association Between ABO Blood Group and Preeclampsia: A Systematic Review and Meta-Analysis.
Li T; Wang Y; Wu L; Ling Z; Li C; Long W; Xie K; Ding H
Front Cardiovasc Med; 2021; 8():665069. PubMed ID: 34235185
[No Abstract] [Full Text] [Related]
8. Fetal cerebro-placental ratio and adverse perinatal outcome: systematic review and meta-analysis of the association and diagnostic performance.
Nassr AA; Abdelmagied AM; Shazly SA
J Perinat Med; 2016 Mar; 44(2):249-56. PubMed ID: 26756084
[TBL] [Abstract][Full Text] [Related]
9. Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies.
Grobman WA; Caughey AB
Am J Obstet Gynecol; 2019 Oct; 221(4):304-310. PubMed ID: 30817905
[TBL] [Abstract][Full Text] [Related]
10. Nonmedically indicated induction in morbidly obese women is not associated with an increased risk of cesarean delivery.
Kawakita T; Iqbal SN; Huang CC; Reddy UM
Am J Obstet Gynecol; 2017 Oct; 217(4):451.e1-451.e8. PubMed ID: 28578171
[TBL] [Abstract][Full Text] [Related]
11. Expectant management of severe preeclampsia with severe fetal growth restriction in the second trimester.
Aoki S; Toma R; Kurasawa K; Okuda M; Takahashi T; Hirahara F
Pregnancy Hypertens; 2014 Jan; 4(1):81-6. PubMed ID: 26104259
[TBL] [Abstract][Full Text] [Related]
12. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
Keulen JK; Bruinsma A; Kortekaas JC; van Dillen J; Bossuyt PM; Oudijk MA; Duijnhoven RG; van Kaam AH; Vandenbussche FP; van der Post JA; Mol BW; de Miranda E
BMJ; 2019 Feb; 364():l344. PubMed ID: 30786997
[TBL] [Abstract][Full Text] [Related]
13. Labor induction versus expectant management for postterm pregnancies: a systematic review with meta-analysis.
Sanchez-Ramos L; Olivier F; Delke I; Kaunitz AM
Obstet Gynecol; 2003 Jun; 101(6):1312-8. PubMed ID: 12798542
[TBL] [Abstract][Full Text] [Related]
14. Management of preeclampsia.
Dekker GA
Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis comparing induction of labour and expectant management for intrauterine growth restriction at term (DIGITAT trial).
Vijgen SM; Boers KE; Opmeer BC; Bijlenga D; Bekedam DJ; Bloemenkamp KW; de Boer K; Bremer HA; le Cessie S; Delemarre FM; Duvekot JJ; Hasaart TH; Kwee A; van Lith JM; van Meir CA; van Pampus MG; van der Post JA; Rijken M; Roumen FJ; van der Salm PC; Spaanderman ME; Willekes C; Wijnen EJ; Mol BW; Scherjon SA
Eur J Obstet Gynecol Reprod Biol; 2013 Oct; 170(2):358-63. PubMed ID: 23910171
[TBL] [Abstract][Full Text] [Related]
16. Variation in outcome reporting in randomized controlled trials of interventions for prevention and treatment of fetal growth restriction.
Townsend R; Sileo F; Stocker L; Kumbay H; Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Kenny L; Bloomfield F; Daly M; Devane D; Papageorghiou A; Khalil A
Ultrasound Obstet Gynecol; 2019 May; 53(5):598-608. PubMed ID: 30523658
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
